<DOC>
	<DOC>NCT00739349</DOC>
	<brief_summary>Study is to assess the safety and efficacy of NOVA22007 0.05% and 0.1% Cyclosporine Ophthalmic Cationic Emulsions QD compared to vehicle for the treatment of the signs and symptoms of dry eye after a 3 month treatment period.</brief_summary>
	<brief_title>NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry Eye</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Male and female 18 years and older Diagnosis of dry eye in both eyes Contraindications to the use of the study medications Known allergy or sensitivity to the study medications or their components Female currently pregnant, nursing, or planning a pregnancy; or woman who has a positive pregnancy test Have participated in an investigational drug or device study within 30 days of Visit 1</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Dry Eye</keyword>
	<keyword>Cyclosporine</keyword>
</DOC>